Here’s an easy way to receive the latest news related to your topic(s) of choice as soon as the articles are published.
1. Copy a url for a topic from the list below.
2. In Outlook, right-click the RSS feeds folder and choose Add a New RSS Feed.
3. Paste the url.
4. Choose Add > OK.
5. Suggestion: Create a subfolder for your topic and an associated rule so they alerts are moved directly into your folder of choice.
|Analysis and data insight|
|Asia-Pacific — Includes Asia-Pacific, Australia, China, Japan
|Australia — Includes Australia, TGA|
|Briefs — Includes appointments and advancements, briefs, deals and M&A, earnings, in the clinic, other news to note, post market, preclinical, products regulatory, products clinical, regulatory actions, regulatory front, stock|
|Canada — Includes Canada, Health Canada
|Cancer — Includes cancer, oncology|
|CAR T — Includes CAR T (Cell therapy), CAR T (Gene therapy), CAR T (Immunotherapy) |
|Cell therapy |
|China — Includes China, NMPA|
|Clinical — Clinical, in the clinic, products clinical|
|Deals and M&A — Includes acquisition, asset purchase, collaboration, co-promotion, deals and M&A, deals and M&A (briefs), development, distribution, equity option, government supply contract, grant, joint venture, license, merger, non-profit, research, research only, reverse merger, royalty buyout, service agreement, settlement, spinout, supply only|
|Diagnostics — Includes artificial intelligence (Diagnostics), biopsy, diagnostics, electrocardiogram, genomics, imaging, liquid biopsy, monitoring, point-of-care|
|Digital health — Includes algorithm, artificial intelligence, cloud-based platform, cybersecurity, database, digital health, electronic health record, mobile/smartphone app, SAAS, SAMD, software, telehealth|
|Drug design, drug delivery and technologies|
|Drugs — Includes antibiotic, antibody, antibody-drug conjugate, antigen, antisense, biosimilar, bispecific antibody, CAR T, cell therapy, drugs, enzyme, gene therapy, generic, immuno-oncology, microbiome, monoclonal antibody, nanotech, natural, oncolytic, peptide, plasma, protein, RNAi, small molecule, vaccine|
|Ear, nose and throat|
|Endocrine/metabolic — Includes diabetes, endocrine/metabolic, obesity|
|Europe — Includes EMA, Europe, MHRA|
|Financings — Includes American depositary shares, at-the-market offering, bought deal offering, credit facility, investment, financings, follow-on, IPO, grant, loan, mezzanine, notes offering, PIPE (private investment of public equity), private, private placement, public, registered direct offering, seed, series A, series B, series C, series D, series E, series F, series G, share issue, warrant exercise|
|Latin America |
|Medical devices and technologies — Includes sub-topics ranging from artificial intelligence to robotic surgery|
|Ministry of Health, Labour and Welfare|
|Medicines and Healthcare products Regulatory Agency|
|Middle East North Africa|
|Newco news — Feature articles on newly emerging companies|
|National Medical Products Administration|
|Ocular — Includes ocular, ophthalmic|
|Omics — Includes genomics, GWAS, metabolomics, omics, proteomics|
|Regulatory — Includes coverage of top regulatory news from global regulatory agencies|
|Substance use and poisoning|
|Therapeutic Goods Administration|
|U.S. — Includes 510(k), CDRH, Central Drugs Standard Control Organization, CMS, FDA, FTC, NIH, orange book, PDUFA, SEC, U.S.|